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Affinity-labeled ~-adrenergic receptor from turkey erythrocyte membranes was specifically cleaved near cysteine residues 
after S-cyanylation. Analysis of the labeled polypeptide fragments suggests that iodocyanopindolol diazirine reacted with 
an amino acid residue which is located in the non-glycosylated region containing the sixth and seventh transmembrane 
domains of the receptor. However, the possibility cannot be excluded that a second residue, located between the third 
and fifth transmembrane domains, was also labeled. Since treatment with either hydroxylamine or triethylamine r sulted 
in removal of the affinity label from the protein, the present study suggests that aspartic or glutamic acid residues are 
present in the adrenergic-binding site which is located in the above-mentioned domains. The procedure for specific chemi- 
cal cleavage of the afffinity-labeled adrenergic receptor should also be useful for future structural and comparative studies 
of other adrenergic receptors. 
Adrenergic receptor, fl-; Affinity labeling; Cysteine cleavage; Receptor-binding site 
1. INTRODUCTION 
Among the numerous proteins belonging to the 
family of membrane r ceptors coupled to proteins 
which bind GTP, the fl-adrenergic receptors have 
been subjected to the most thorough investigation 
of both their physiological nd structural proper- 
ties (review [1]). The turkey Z?-adrenergic receptor 
(tflAR), isolated from erythrocyte plasma mem- 
branes, was one of the first receptors of this type 
for which the amino acid sequence was determined 
[2]. Although a putative model of its folding in the 
membrane was deduced from sequence homology 
and resemblance to the light receptor hodopsin, 
the exact nature and location of the catecholamine- 
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binding site require further investigation. Recent 
studies employing site-directed mutagenesis 
[1,3,4], selective proteolysis [5], affinity labeling 
[6] and other methods [1] demonstrated that the 
binding site comprises residues belonging to 
several of the seven transmembrane domains and 
established the importance of some amino acids, 
such as aspartates located in these domains, for 
ligand binding. 
Here, we have used photoaffinity labeling 
together with chemical and enzymatic approaches 
to characterize further the location and chemical 
nature of the residues which are involved in the 
ligand-binding site of t,6'AR. The procedure for 
specific chemical cleavage of the affinity-labeled 
adrenergic receptor described here should be useful 
for future structural and comparative studies of 
other adrenergic receptors. 
2. EXPERIMENTAL 
2.1. Affinity labeling of t~AR and gel electrophoresis 
Turkey erythrocyte plasma membranes were prepared as 
described [7]. Affinity labeling of the membranes with 
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[~25I]iodocyanopindolol iazirine (ICD) [8] was performed as 
reported [9] except hat the ICD concentration was 100 pM, 
and the labeled membranes were stored at -70°C at a protein 
concentration of 6 mg/ml. Electrophoresis on 15% 
polyacrylamide gels in the presence of SDS and 
autoradiography were performed as in [9]. All procedures 
described in this and subsequent sections were carried out at 
0°C unless otherwise indicated. 
2.2. S-cyanylation faffinity-labeled membranes 
Affinity-labeled membranes (100/A) were suspended in 
10 mM Tris-HCl (pH 8) and centrifuged at 20000 × g for 
20 rain. The pellet was suspended in 100/A of 0.2 M Tris-HC1 
and 1 mM EDTA (pH 8, buffer A), and distributed equally into 
five tubes (samples a-e). Following incubation of (a) and (b) at 
37°C for 2 h, all tubes were recentrifuged asabove. Samples 
(a)-(d) were each suspended in40/al buffer A containing 8M 
urea (BRL, ultra pure grade), 10 mM dithiothreitol and 1°70 
SDS, and incubated at 37°C for 1 h; sample (e) was resuspend- 
ed in buffer A (40/A). 2/d of 1 M 2-nitro-5-thiocyanobenzoic 
acid (NTCB, Fluka) [10] in ethanol was then added to samples 
(a), (c) and (e). After incubation of all samples at 37°C for 
30 min, the pH was raised to 9 by addition of 3 M Tris base 
(-3.5/d), followed by further incubation at 37°C for 20 h. 
Electrophoresis ample buffer (5 ×) was then added and elec- 
trophoresis and autoradiography were performed as described. 
2.3. Enzymatic treatments with Staphylococcus aureus 1/8 
protease and endoglycosidase F 
Affinity-labeled membranes (200 ,ul) were treated with NTCB 
as described above [section 2.2, sample (c)]. The resulting reac- 
tion mixture was applied to two wells (100,ul in each) of a 
polyacrylamide gel. Following electrophoresis, the gel was 
autoradiographed at - 70°C for 15 h and areas on the gel cor- 
responding to labeled polypeptide fragments ( ee section 3.2) 
were excised from the two equivalent lanes. The individual 
fragments of one lane were treated with S. aureus V8 protease 
[11], run in parallel with the untreated fragments on a second 
gel and autoradiographed as described. 
NTCB-treated membranes [ ection 2.2, sample (c)] and 
affinity-labeled membranes (100/zl of each) were separately 
dialyzed against 0.1 M NaH2PO4 (pH 6.1) containing 50 mM 
EDTA, 0.1 °7o SDS and 0.1 °7o ~'-mercaptoethanol. N nidet P-40 
(Sigma, 20°7o in water) was then added to give a final concentra- 
tion of 1°70 (final volume 140/zl). Endoglycosidase F (NEN, 
700 U/ml, 0.5/A) was added to half the volume of each sample, 
and the four samples were incubated at 37°C for 15 h. After ad- 
dition of electrophoresis ample buffer (5 × ) the samples were 
subjected to electrophoresis and autoradiography. 
2.4. Reaction wRh hydroxylamine and triethylamine 
Affinity-labeled membranes (100/d) were suspended in 
10 mM Tris-HCl (pH 8) and centrifuged at 20000 x g for 
20 min. The pellet was suspended in 100/A buffer A containing 
8 M urea and 1°7o SDS, incubated at 37°C for l h and divided 
equally into five aliquots. Each aliquot of the solubilized la- 
beled membranes was mixed with 20/d of" (a) 2 M hydrox- 
ylamine hydrochloride in 0.2 M NazCO~, 1 °70 SDS and 8 M 
urea (pH 8); (b) same as (a) but without hydroxylamine 
hydrochloride; (c) buffer A saturated with triethylamine at
23°C; (d) buffer A titrated with NaOH to pH 12; (e) buffer A. 
After all samples were incubated at 37°C for l h, they were 
each mixed with 10/A electrophoresis ample buffer (5 × ) and 
subjected to gel electrophoresis and autoradiography. 
3. RESULTS AND DISCUSSION 
3.1. Affinity labeling of  tZ~AR 
Aff in i ty labeling of turkey erythrocyte mem- 
branes with ICD yielded two specifically labeled 
polypeptides of 42 and 50 kDa (f ig.l ,  lane l) cor- 
responding to the tBAR [12]. When the affinity- 
labeled membranes were incubated at 37°C for 
1 h, prior to their solubil ization in the gel elec- 
trophoresis ample buffer, only the 42 kDa band 
was obtained (fig. 1, lane 2); this polypeptide has 
been shown to represent a proteolytic degradation 
product of the 50 kDa polypeptide, lacking the 
glycosylated N-terminal segment of the receptor 
[12]. 
3.2. Cleavage o f  tflAR by NTCB 
Following cleavage of the solubilized affinity- 
labeled t4YAR by NTCB, three labeled polypeptide 
fragments of 18, 23 and 28 kDa (F18, F23 and 
F28, respectively) were revealed after gel elec- 
trophoresis and autoradiography (f ig.l ,  lane 3). 
Complete cleavage of the receptor was achieved 
when both modif icat ion and cleavage were carried 
out in the presence of 1°70 SDS, 8 M urea and 
10 mM dithiothreitol; no further cleavage into 
smaller fragments could be observed when higher 
concentrat ions of the reagents or longer reaction 
times were employed. Incomplete cleavage of the 
labeled receptor esulted when urea, or reduction 
with dithiothreitol prior to reaction with NTCB, 
were omitted (not shown). Cleavage of the 
solubilized 42 kDa affinity-labeled polypeptide 
(see section 3.1) by NTCB resulted in three labeled 
fragments (18, 23 and 28 kDa) identical to those 
obtained after cleavage of the affinity-labeled 
t45'AR (f ig.l ,  lane 4), suggesting that these 
fragments lack the N-terminal region of the 
receptor. 
As shown in fig. 1 (lane 5), two addit ional la- 
beled fragments were obtained (F21 and F37 cor- 
responding to 21 and 37 kDa) when intact 
aff inity-labeled turkey membranes were treated 
with NTCB in the absence of SDS and urea. 
Previous attempts to cleave specifically the 
aff inity-labeled receptor by other chemical means, 
such as treatment with CNBr, resulted in cleavage 
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Fig. 1. Gel electrophoresis autoradiography of the affinity-labeled t~'AR and its NTCB fragments. Lanes: (1) affinity-labeled turkey 
erythrocyte membranes; (2)as lane 1 but after incubation at 37°C for 1 h prior to electrophoresis; (3) solubilized affinity-labeled 
membranes treated with NTCB; (4) NTCB treatment ofsolubilized labeled membranes after incubation at37°C for I h; (5) NTCB 
treatment ofintact labeled membranes; (6,7) labeled membranes reacted with triethylamine or hydroxylamine, r spectively; left lane, 
molecular mass markers. Arrows indicate polypeptides of interest mentioned in section 3; for experimental details ee text. 
and loss of the label due to the reaction conditions 
(unpublished and [6]). The mild conditions used in 
our procedure did not lead to removal of the label 
from the protein, and enabled specific cleavage by 
NTCB to yield labeled fragments that could be fur- 
ther analyzed and characterized. 
3.3. Enzymatic treatments of NTCB-labeled 
fragments 
Incubation of the affinity-labeled 50 kDa recep- 
tor with endoglycosidase F resulted in a change in 
its electrophoretic migration corresponding to a 
molecular mass of 45 kDa (not shown), as de- 
scribed before [12], indicating that the carbo- 
hydrate moiety located in the N-terminal region 
[2,7] of the affinity-labeled t45'AR was removed by 
the glycosidase. Upon treatment of the NTCB- 
labeled fragments (FI8, F23, F28) with en- 
doglycosidase F, an electrophoretic pattern iden- 
tical to that of the untreated fragments (fig. 1, lane 
3) was observed. This finding supports our 
previous conclusion (see section 3.2) that these 
fragments originated from the non-glycosylated 
region of the affinity-labeled receptor. 
When labeled fragments F18, F23 and F28 were 
subjected, separately or as a mixture, to treatment 
with S. aureus V8 protease, all three yielded a 
polypeptide with an identical molecular mass of 
17 kDa (fig.2, lanes 4-6). A polypeptide of 
17 kDa was also the main product obtained when 
the solubilized affinity-labeled receptor was sub- 
jected to digestion by this protease (not shown). 
3.4. Localization of the labeled fragments in the 
receptor polypeptide chain 
Reaction of the affinity-labeled receptor with 
NTCB under the various conditions used did not 
apparently result in cleavage of all 19 cysteine 
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Fig.2. Gel electrophoresis autoradiography of affinity-labeled 
NTCB fragments of affinity-labeled t,6'AR treated with S. 
aureus  V8 protease according to [11]. Lanes: (1-3) NTCB 
fragments of 28, 23 and 18 kDa, respectively, separated 
previously by gel electrophoresis; (4-6) same fragments as in 
lanes 1-3, treated with the V8 protease; middle lane, molecular 
mass markers. Arrrows denote fragments of interest discussed 
in the text. 
residues located along the polypeptide chain [2]; 
indeed, the smallest labeled polypeptide observed 
after cleavage was still twice the size (15 kDa) of 
the longest segment between two neighbouring cys- 
teine residues present in the protein (Cysl°-CysSS). 
It has been previously established that integral 
membrane proteins, such as the human erythrocyte 
band 3 [13-16], are not susceptible to cleavage by 
NTCB in 1% SDS at cysteine residues located in 
hydrophobic domains (usually embedded in the 
lipid bilayer). Based on this knowledge, we as- 
sumed that the cysteine residues present in the 
transmembrane domains of the tDAR [2] were not 
cleaved by NTCB. Since F18, F23 and F28 do not 
contain the carbohydrate moiety of t45'AR, they 
should be located between Cys H4 and the C- 
terminal end. The 17 kDa labeled polypeptide 
resulting from cleavage of these fragments by S. 
aureus  V8 is suggested to be common to all of 
them. Analysis of the possible overlap between the 
molecular masses of the NTCB fragments and 
those of polypeptides located between possible 
cleavage sites in the primary structure of the recep- 
tor led to the localization of these affinity-labeled 
fragments proposed in fig.3A. 
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Fig.3. Schematic representation f the localization of the NTCB affinity-labeled fragments in the primary structure of t~AR. (A,B) 
Fragments obtained from cleavage of solubilized or intact affinity-labeled membranes, respectively: F18, F24 and F28 are proposed 
to have Cys ~gs (or Cys ~99) as their N-terminal and Leu 357, Asp 397 and Tyr 437 as their respective C-terminals, based on their molecular 
mass and those of the domains between the cysteine residues in the primary structure. However, it is possible that F28 is also located 
between Cys TM (or Cys 116) and Leu 35~ (designated F28'). This alignment supports the suggestion of a 17 kDa polypeptide common 
to these fragments (F17, between Cys~gS-Phe TM and Asp34S), obtained after their cleavage by V8 protease. F37 and F21, obtained 
following NTCB cleavage of intact labeled membranes, are proposed to have Tyr 437 as their C-terminal and Cys H4 (or Cys ll6) and 
Cys TM as their respective N-terminals. Arrows indicate proposed cleavage sites of cysteine residues; numbers indicate the position in 
the primary structure; I-VII represent the transmembrane domains of the receptor [2]; (e) Cys residues; (o) Asp residue; (y )  
carbohydrate moiety. 
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The observation that cleavage by NTCB of 
solubilized or intact affinity-labeled membranes 
resulted in more than one labeled fragment in each 
case (fig. 1, lanes 3,5) implies incomplete modifica- 
tion or cleavage due to side reactions uch as/5- 
elimination [10]. It is worth noting that the 
cytoplasmic Cys 244 probably reacted with NTCB in 
the intact membranes to yield F21 (fig.3B), but not 
in membranes olubilized in SDS. The proposed 
alignment of all the fragments obtained (fig.3) 
clearly suggests that the affinity label is attached to 
the receptor in the region located between Cys TM 
and Asp 348, containing part of the third 
cytoplasmic loop and the sixth and seventh 
transmembrane domains. 
As shown in fig.3A, F28 could also be matched 
with the domain located between Cys  114 and 
Leu 357. We have observed that when cleavage with 
NTCB was performed in the presence of 10 mM 
dithiothreitol n intact membranes which were af- 
finity labeled with higher concentrations of ICD 
(500 pM), a labeled fragment of 15 kDa which can 
overlap with the sequence between Cys lt4 and 
Arg 243 was also observed (not shown). Therefore, 
the possibility that the affinity label can also react, 
under certain conditions, with an amino acid 
located between the third and fifth transmembrane 
regions cannot be excluded. 
3.5. Cleavage with hydroxylamine and 
triethylamine 
Reaction of the solubilized affinity-labeled 
tflAR, or of the NTCB-treated receptor, with 
either hydroxylamine or triethylamine, resulted in 
almost complete (>95°7o) removal of the label 
from both the intact receptor (fig. 1, lanes 6,7) and 
its NTCB fragments. In the control experiment, 
neither the labeled receptor nor the labeled 
fragments revealed any loss of radioactivity or 
change in their mobility, when incubated under the 
same conditions but in the absence of hydrox- 
ylamine or triethylamine. These results imply that 
the affinity label ICD is covalently bound to the 
turkey adrenergic receptor via an ester bond, i.e. to 
the carboxylate side chain of either aspartic or 
glutamic acid residues which reside in the binding 
site. 
3.6. Concluding remarks 
The results described here suggest that the affini- 
ty labeling with ICD occurs on an aspartic or 
glutamic acid residue located in or near the sixth or 
seventh transmembrane domain of t,6'AR. An addi- 
tional carboxylate is possibly labeled in the region 
between the third and fifth transmembrane do- 
mains. These results are in support of a recent 
study [6] which demonstrated that Trp 33°, located 
in the seventh transmembrane domain, and an 
unidentified residue, located between the third and 
fifth transmembrane domains, were affinity la- 
beled by iodoazidobenzylpindolol. 
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